[ad_1]
IWT notes that in the first month of vaccination, people were vaccinated with two vaccines that were on the Lithuanian market at the time. The third vaccine started in early February. The number of IDR reports received during the entire vaccination period is 0.5 percent of the vaccine doses used. Since the start of vaccination, 729 notifications have been received for Comirnaty, 61 notifications for COVID-19 Vaccine Moderna, and 401 notifications for COVID-19 Vaccine AstraZeneca. The name of the vaccine was not provided in the 10 RNA reports received.
The IUDC reports that during the second month of vaccination, it received 890 initial reports of NSAIDs in Lithuania related to the use of COVID-19 vaccines. There were 432 reports of CNS after Comirnaty administration, 48 reports of CNS after the COVID-19 Vaccine Moderna vaccine, and 401 reports of COD after the COVID-19 AstraZeneca vaccine. The name of the vaccine was not mentioned in 9 RNA reports. Sudden deaths of two elderly patients were also reported during the second month of vaccination. Both cases were assessed as unrelated to vaccination.
868 messages are classified as mild to moderate and 22 as severe. Women reported more CNS reports than men, 817 and 73 reports, respectively. The age range for CIS reporters is 19 to 87 years old. The number of reports received from health professionals is 86, from patients – 799; 5 notifications received from the Eudravigilance database.
The main reports received by the Office of People Vaccinated against COVID-19 were fever, headache, muscle aches, nausea, and injection site reactions. Most of these reactions were mild to moderate in severity and resolved after a few days.
The SCCP recalls that the Summary of Product Characteristics and the package insert for registered COVID-19 vaccines include recommendations and precautions to be followed by healthcare professionals and patients to use the vaccines safely and effectively. As with all medicines, data on vaccine use is constantly monitored. Every COI report for COVID-19 vaccines received by ICD is carefully evaluated and all necessary steps are taken to protect patients.
The SCCP also notes that health professionals (doctors, nurses) have been informed of the suspected adverse reaction as soon as possible, but no later than 15 days after the suspected adverse reaction to the vaccine and / or or has received the information. a report of suspected adverse reaction (ADR) to the IWT pharmacy or healthcare specialist. You can report:
- completing the form directly online.
- by filling in the specialist notification form (can be found here) and emailing it to [email protected].
Users themselves can also record the side effects of vaccines. The notification can be sent in the following ways:
- filling in the form directly online;
- by filling out the Patient Notification Form (available here) and emailing it to [email protected]);
- freephone 8800 73568.
When reporting an IRR, IWT does not need to provide your personal data, IWT only asks for contact information so that we can contact you if necessary. All data provided in the report is secure and confidential. If a patient does not want to report CPR themselves, they can ask someone else, such as a healthcare professional or pharmacist, to do so. However, the Office needs to know the age and sex of a person who has experienced an ICE, as this information is important to investigate and evaluate the factors that can lead certain patients to an ICE.
If you have any questions about the COVID-19 vaccine, please send them to our editorial office at [email protected]
[ad_2]
